intoDNA Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

intoDNA General Information

Description

Developer of a DNA damage detection platform designed to provide precise measurement of DNA breaks at the individual lesion level. The company's platform utilizes proprietary AI algorithms to directly detect and quantify single- and double-strand DNA breaks in various biological materials, enabling pharmaceutical companies and research laboratories to gain critical insights for drug discovery and the development of targeted therapies.

Contact Information

Website
www.intodna.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ul. Bobrzyńskiego
  • Krakow, 30-348
  • Poland
+48 12
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Other Healthcare Services
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • Ul. Bobrzyńskiego
  • Krakow, 30-348
  • Poland
+48 12

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

intoDNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 19-Feb-2026 Completed Generating Revenue
5. Angel (individual) 14-Aug-2025 Completed Generating Revenue
4. Grant 20-Dec-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 25-May-2020 Completed Generating Revenue
2. Seed Round 23-Dec-2019 $65.9K Completed Generating Revenue
1. Accelerator/Incubator 30-Jul-2018 $65.9K $65.9K Completed Generating Revenue
To view intoDNA’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

intoDNA Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

intoDNA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024246753-A1 Method for detection of nucleic acid end(s) Pending 30-Mar-2023
EP-4689153-A1 Method for detection of nucleic acid end(s) Pending 30-Mar-2023
US-20260275403-A1 Method for detection of nucleic acid end(s) Pending 30-Mar-2023
WO-2024200750-A1 Method for detection of nucleic acid end(s) Inactive 30-Mar-2023
EP-4438738-A1 Method of detection of dna end(s) Inactive 30-Mar-2023 C12Q1/6804
To view intoDNA’s complete patent history, request access »

intoDNA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

intoDNA Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
SMOK Angels Angel Group Minority
Polish Agency for Enterprise Development Government
To view intoDNA’s complete investors history, request access »

Ready to get started?

Request a free trial

intoDNA FAQs

  • When was intoDNA founded?

    intoDNA was founded in 2017.

  • Where is intoDNA headquartered?

    intoDNA is headquartered in Krakow, Poland.

  • What is the size of intoDNA?

    intoDNA has 41 total employees.

  • What industry is intoDNA in?

    intoDNA’s primary industry is Laboratory Services (Healthcare).

  • Is intoDNA a private or public company?

    intoDNA is a Private company.

  • What is intoDNA’s current revenue?

    The current revenue for intoDNA is .

  • How much funding has intoDNA raised over time?

    intoDNA has raised $65.9K.

  • Who are intoDNA’s investors?

    SMOK Angels and Polish Agency for Enterprise Development have invested in intoDNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process